Fluconazole prophylaxis for prevention of invasive fungal infections in targeted highest risk preterm infants limits drug exposure (Q46815330)

25 December 2017

title

Fluconazole prophylaxis for prevention of invasive fungal infections in targeted highest risk preterm infants limits drug exposure (English)

1 reference

25 December 2017

invasive fungal infections

1 reference

1 reference

1 reference

J-H Weitkamp

1 reference

25 December 2017

A Ozdas

series ordinal

1 reference

25 December 2017

B LaFleur

series ordinal

1 reference

25 December 2017

A L Potts

series ordinal

1 reference

25 December 2017

publication date

10 January 2008

1 reference

25 December 2017

published in

Journal of Perinatology

1 reference

25 December 2017

volume

1 reference

25 December 2017

issue

1 reference

25 December 2017

page(s)

405-411

1 reference

25 December 2017

Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211914

Risk factors for candidemia in critically ill infants: a matched case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211914

Risk factors for candidemia in Neonatal Intensive Care Unit patients. The National Epidemiology of Mycosis Survey study group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211914

When to suspect fungal infection in neonates: A clinical comparison of Candida albicans and Candida parapsilosis fungemia with coagulase-negative staphylococcal bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211914

Fluconazole prophylaxis against fungal colonization and infection in preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211914

Twice weekly fluconazole prophylaxis for prevention of invasive Candida infection in high-risk infants of <1000 grams birth weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211914

Impact of fluconazole prophylaxis on incidence and outcome of invasive candidiasis in a neonatal intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211914

Fluconazole prophylaxis prevents invasive fungal infection in high-risk, very low birth weight infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211914

Prophylactic fluconazole is effective in preventing fungal colonization and fungal systemic infections in preterm neonates: a single-center, 6-year, retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211914

Selective fluconazole prophylaxis in high-risk babies to reduce invasive fungal infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211914

Targeted short-term fluconazole prophylaxis among very low birth weight and extremely low birth weight infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211914

A multicenter, randomized trial of prophylactic fluconazole in preterm neonates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211914

Fluconazole prophylaxis in extremely low birth weight infants: association with cholestasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211914

Fungal chemoprophylaxis with fluconazole in preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211914

Antifungal prophylaxis to prevent neonatal candidiasis: a survey of perinatal physician practices

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211914

Reducing Candida infections during neonatal intensive care: management choices, infection control, and fluconazole prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211914

Fluconazole for the prevention of fungal infections: get ready, get set, caution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211914

Changing incidence of Candida bloodstream infections among NICU patients in the United States: 1995-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211914

Prior antimicrobial therapy and risk for hospital-acquired Candida glabrata and Candida krusei fungemia: a case-case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211914

Risk factors for Candida species colonization of neonatal intensive care unit patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211914

7 January 2021

Excess costs of hospital care associated with neonatal candidemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211914

7 January 2021

Prophylactic intravenous antifungal agents to prevent mortality and morbidity in very low birth weight infants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211914

7 January 2021

Antifungal agents for preventing fungal infections in solid organ transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211914

7 January 2021

National epidemiology of mycoses survey (NEMIS): variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211914

7 January 2021

Safety and tolerability of fluconazole in children

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211914

7 January 2021

Identifiers

DOI

10.1038/SJ.JP.7211914

1 reference

25 December 2017

1 reference

25 December 2017